Navigation Links
Myriant Produces Succinic Acid and Lactic Acid From Non-Food Cellulosic Feedstocks
Date:10/5/2011

QUINCY, Mass., Oct. 5, 2011 /PRNewswire/ -- Myriant Corporation today announced the successful development of its proprietary process for producing targeted bio-based chemicals, including succinic acid and both L(+) and D(-) lactic acid, from non-food, renewable, cellulosic feedstocks.

(Logo: http://photos.prnewswire.com/prnh/20110531/NE11071LOGO)

"Today's announcement is a significant step forward in our ability to continue driving the advancement and global use of cellulosic materials as the foundation for manufacturing of bio-based chemicals," said Stephen Gatto, CEO and Chairman of Myriant Corporation.  "We recognized early on that these renewable feedstocks were a critical component of the technology platform for our succinic acid and lactic acid programs."

This development is an integral part of Myriant's manufacturing and commercialization strategy. "We believe that Myriant's ability to use non-food cellulosic feedstocks, as opposed to traditional food-based or petroleum-based feedstocks, gives it a critical global competitive advantage," said Mr. Gatto.  The ability to take advantage of these abundant low-cost feedstocks allows Myriant to roll out its succinic acid and lactic acid manufacturing platforms throughout the world, without being restricted to scarce availability and expensive food-based feedstocks.  Furthermore, it provides stable feedstock pricing, which will enable Myriant to offer its customers long term price stability.

In 2009, Myriant was awarded $50 million from U.S. Department of Energy, which supports the company's construction of its 30 million pound succinic acid facility in Lake Providence, Louisiana and the commercialization of its cellulosic succinic acid program. "The results achieved today testify to Myriant's continued leadership in the manufacture of cost-effective bio-based chemical intermediates and builds off of Myriant's core competency in industrial bio-technology," added Mr. Gatto.

The use of cellulosic biomass, an abundant global resource, will provide a renewable feedstock manufacturing base for many next-generation, bio-derived products. The success of the biochemical industry is highly dependent on a cost-effective, high-quality, and functional supply of sustainable biomass feedstocks.

About Myriant

Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable commercialization of high-value bio-based chemicals. In December 2010, Myriant broke ground on its 30 million pound commercial succinic acid facility in Lake Providence, Louisiana. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant has announced agreements with Uhde GmbH for engineering, Davy Process Technology for the integration of Myriant's succinic acid process with the Davy butanediol process for the production of bio-based butanediol, and PTT Chemical for the commercialization of Myriant's technology in South East Asia.

Myriant is headquartered in Quincy, Massachusetts. Details are available at www.myriant.com.

Contact:
Samuel G. McConnell, Sr.VP, Corporate Development
Telephone:  (617) 657-5207
Email: smcconnell@myriant.com


'/>"/>
SOURCE Myriant Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Myriant Technologies, Inc. Announces J. Brian Ferguson to Join Advisory Board
2. Myriant Technologies, Inc. Announces US$60 Million Strategic Equity Investment From PTT Chemical Group
3. Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence
4. Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project
5. Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants
6. Myriant Technologies LLC Announces Appointment of Science Advisory Board Members
7. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
8. Pixantrone in Combination with Fludarabine, Dexamethasone and Rituximab Produces High Rates of Complete Remissions in Patients with Relapsed or Refractory Indolent Non-Hodgkins Lymphoma
9. Optical microscope without lenses produces high-resolution 3-D images on a chip
10. Templated growth technique produces graphene nanoribbons with metallic properties
11. Nanotech milling produces dramatic increase in thermoelectric performance of bulk semiconductor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... 30, 2016  The Allen Institute for Cell ... first publicly available collection of gene edited, fluorescently ... key cellular structures with unprecedented clarity. Distributed through ... tools are a crucial first step toward visualizing ... what makes human cells healthy and what goes ...
(Date:11/30/2016)... Nov. 30, 2016  Tempus, a technology company ... and Penn,s Abramson Cancer Center have partnered to ... response to immunotherapy treatment based on next generation ... part of a research collaboration, Tempus will provide ... cancer patient data to Penn. Utilizing next-generation sequencing, ...
(Date:11/30/2016)... 2016   Merck , ein führendes ... einer Reihe von Vereinbarungen mit Evotec AG ... Screeningleistungen für Mercks Palette genetischer Reagenzien wie ... diese Bibliotheken in Kombination mit Evotecs Expertise ... zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
(Date:11/30/2016)... BILLERICA, Mass. , Nov. 30, 2016   ... announced that it has entered into a set of ... screening services for Merck,s collection of genetic reagents such ... libraries with Evotec,s screening expertise offers an accelerated pathway ... "Drug discovery starts with the identification of new targets, ...
Breaking Biology Technology:
(Date:11/21/2016)...   Neurotechnology , a provider of high-precision ... that the MegaMatcher On Card fingerprint matching algorithm ... NIST Minutiae Interoperability Exchange (MINEX) III ... of the evaluation protocol. The ... fingerprint templates used to establish compliance of template ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:6/22/2016)... 2016  The American College of Medical Genetics and Genomics ... as one of the fastest-growing trade shows during the ... Bellagio in Las Vegas . ... growth in each of the following categories: net square feet ... of attendees. The 2015 ACMG Annual Meeting was ranked 23 ...
Breaking Biology News(10 mins):